THE RODENT UTEROTROPHIC ASSAY - CRITICAL PROTOCOL FEATURES, STUDIES WITH NONYL PHENOLS, AND COMPARISON WITH A YEAST ESTROGENICITY ASSAY

Citation
J. Odum et al., THE RODENT UTEROTROPHIC ASSAY - CRITICAL PROTOCOL FEATURES, STUDIES WITH NONYL PHENOLS, AND COMPARISON WITH A YEAST ESTROGENICITY ASSAY, Regulatory toxicology and pharmacology, 25(2), 1997, pp. 176-188
Citations number
31
Categorie Soggetti
Medicine, Legal","Pharmacology & Pharmacy",Toxicology
ISSN journal
02732300
Volume
25
Issue
2
Year of publication
1997
Pages
176 - 188
Database
ISI
SICI code
0273-2300(1997)25:2<176:TRUA-C>2.0.ZU;2-Q
Abstract
The major protocol features of the immature rat uterotrophic assay hav e been evaluated using a range of reference chemicals. The protocol va riables considered include the selection of the test species and route of chemical administration, the age of the test animals, the maintena nce diet used, and the specificity of the assay for estrogens. It is c oncluded that three daily oral administrations of test chemicals to 21 - to 22-day-old rats, followed by determination of absolute uterus wei ghts on the fourth day, provide a sensitive and toxicologically releva nt in vivo estrogenicity assay. Rats are favored over mice for reasons of toxicological practice, but the choice of test species is probably not a critical protocol variable, as evidenced by the similar sensiti vity of rats and mice to the uterotrophic activity of methoxychlor. Va ginal opening is shown to be a useful, but nondefinitive, adjunct to t he uterotrophic assay. The ability of test chemicals to reduce or abol ish the uterotrophic response of estradiol is suggested to provide a u seful extension of the uterotrophic assay for the purpose of detecting antiestrogens. The results of a series of studies on the environmenta l estrogen nonyl phenol (NP), and its linear isomer n-nonyl phenol, co nfirm that branching of the aliphatic side chain is important for acti vity. 17 beta-Desoxyestradiol is shown to be of similar activity to es tradiol in the uterotrophic assay and is suggested to represent the '' parent'' estrogen of NP. Benzoylation of NP and 17-desoxyestradiol did not affect their uterotrophic activity, in contrast to the enhancing effect of benzoylation on estradiol. Selected chemicals shown to be ac tive in the immature rat uterotrophic assay were also evaluated in an in vitro yeast human estrogen receptor transactivation assay. Most of the chemicals gave similar qualitative responses to those seen in the uterotrophic assay, and the detection of the estrogen methoxychlor by the yeast assay evidenced a degree of intrinsic metabolic competence. However, the assay had a reduced ability (compared to rodents) to hydr olyze the benzoate ester of estradiol, and the estrogenic benzoate der ivative of NP was not active in the yeast assay. These last results in dicate that current metabolic deficiencies of in vitro estrogenicity a ssays will limit the value of negative data for the immediate future. The results described illustrate the intrinsic complexity of evaluatin g chemicals for estrogenic activities and confirm the need for rigorou s attention to experimental design and criteria for assessing estrogen ic activity. (C) 1997 Academic Press.